期刊文献+

Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method 被引量:5

Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method
下载PDF
导出
摘要 The objective of this work is to construct a nanosuspension drug delivery system of probucol,a BCS II drug,in order to improve its dissolution and oral bioavailability.The wet milling procedure using planetary beads-milling equipment was utilized to grind the raw probucol to ultrafine nanoparticle/nanocrystal aqueous suspension that was further solidified by freeze-drying process.Cellulose derivatives of different substitution groups and molecular weights,including HPMC,HPC,and MC,were evaluated as the primary stabilizer of probucol nanosuspension.Ternary stabilizers system composed of a primary stabilizer(cellulose derivative,i.e.HPC),a nonionic surfactant(Pluronic R F68),and an anionic surfactant(SDS)was employed to obtain probucol nanosuspension of finer particle size and enhanced dissolution in aqueous media.The probucol nanosuspension with good physical stability showed no obvious change of particle size even after storing over 7 d at 4°C or 25°C.The solidified probucol nanosuspension with trehalose as the cryoprotectant showed the highest dissolution rate(>60%at 2 h)compared to other cryoprotectant.The in vivo pharmacokinetic evaluation indicated about 15-folds higher AUC value of the probucol nanosuspension compared to that of coarse probucol suspension after oral administration to rats.The probucol nanosuspension prepared by wet-milling and ternary stabilizers system may find wide applications for improving the dissolution and oral absorption of water-insoluble drugs. The objective of this work is to construct a nanosuspension drug delivery system of probucol, a BCS II drug, in order to improve its dissolution and oral bioavailability. The wet milling procedure using planetary beads-milling equipment was utilized to grind the raw probucol to ultrafine nanoparticle/nanocrystal aqueous suspension that was further solidified by freeze-drying process. Cellulose derivatives of different substitution groups and molecular weights, including HPMC, HPC, and MC, were evaluated as the primary stabilizer of probucol nanosuspension. Ternary stabilizers system composed of a primary stabilizer(cellulose derivative, i.e. HPC), a nonionic surfactant(Pluronic~?F68), and an anionic surfactant(SDS) was employed to obtain probucol nanosuspension of finer particle size and enhanced dissolution in aqueous media. The probucol nanosuspension with good physical stability showed no obvious change of particle size even after storing over 7 d at 4 °C or 25 °C. The solidified probucol nanosuspension with trehalose as the cryoprotectant showed the highest dissolution rate( > 60% at 2 h) compared to other cryoprotectant. The in vivo pharmacokinetic evaluation indicated about 15-folds higher AUC value of the probucol nanosuspension compared to that of coarse probucol suspension after oral administration to rats. The probucol nanosuspension prepared by wet-milling and ternary stabilizers system may find wide applications for improving the dissolution and oral absorption of water-insoluble drugs.
出处 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2019年第6期649-657,共9页 亚洲药物制剂科学(英文)
基金 financial support from the National Basic Research Program of China(973 Program,No.2009CB930300)
关键词 PROBUCOL NANOSUSPENSION Ternary STABILIZERS systems PLANETARY beads-milling Bioavailability Probucol Nanosuspension Ternary stabilizers systems Planetary beads-milling Bioavailability
  • 相关文献

参考文献1

二级参考文献5

  • 1[1]Schwartz CJ. Introduction-the probucol experience: a review of the past and a look at the future [J].Am J Cardiol,1988,62(3):1B.
  • 2[2]Heel RC,Brogden RN, Speight TM, et al.Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolemia [J]. Drug, 1978,15 (6) :409.
  • 3[3]Rodes J, Cote G, Lesperance J, et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol [J] . Circulation,1998,97(5) :429.
  • 4[4]Kudo S, Akiyama H, Odomi M, et al. High-performance liqid chromatographic procedure for the determination of probucol in human plasma [J]. J Chromatogr, 1983,277(2) :419.
  • 5[5]Jaffar NZ, Nitin KG, Louise AF, et al. Measurement of plasma probucol levels by high-performance liqid chromatography [J]. J Chromatogr Biomed, 1994,654(1) :55.

共引文献3

同被引文献68

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部